(PRWEB) October 26, 2012
The US Drug Watchdog has launched a very aggressive national initiative focused on identifying all women recipients of a transvaginal mesh, tape, or sling, who are now severely damaged by this type of product. Transvaginal mesh products were designed for women, who were suffering from pelvic organ prolapse, and stress urinary incontinence. Initially the US FDA called the procedure to install a transvaginal mesh, tape, or sling-minimally-invasive. According to court records, women who experience a transvaginal mesh failure may need to have numerous corrective surgeries, IV therapy, blood transfusions and drainage of hematomas or abscesses. The US Drug Watchdog is offering to help all US women, who are now victim's of a transvaginal mesh, sling, or tape failure get to the best possible attorneys, and the group is promising the attorneys at least initially will all be women. For more information victims of a Transvaginal Mesh failure are urged to contact the US Drug Watchdog anytime at 866-714-6466, or contact the group via their web site at http://USDrugWatchdog.Com
The US Drug Watchdog is indicating symptoms of a vaginal mesh, tape, or sling failure may include:
The US Drug Watchdog says, "One of the biggest problems we have with respect to our failed medical device or recalled drug initiative work is the average US consumer never hears about a drug recall or failures involving medical devices like the transvaginal mesh, tape, or a sling. If you have a friend, or loved one who is a recipient of a transvaginal mesh, sling, or tape that has already failed or is showing symptoms of a failure, please have them call us at 866-714-6466. We want to make certain all transvaginal mesh, tape, or sling victims get to the best possible attorneys, to ensure they get the best possible compensation for their ordeal, and we will do our absolute best to make certain all of the attorneys are initially women." http://USDrugWatchdog.Com
U.S. District Court for the Southern District of West Virginia Multi District litigation (MDL) consolidates all similar cases into one courtroom and will include the Defendants:
C.R. Bard, Inc., (MDL No. 2187);
American Medical Systems Inc., MDL No. 2325);
Boston Scientific Corp., (MDL No. 2326); and Johnson & Johnson's Ethicon, Inc. (MDL No. 2327)